Comparison of the Efficacy of Interleukin-23 Inhibitors in the Treatment of Psoriasis in a Tertiary Care Hospital
Interleukin-23 (IL-23) is a key cytokine in the pathophysiology of psoriasis, and its inhibition has proven highly effective in managing this chronic inflammatory disease
Authors
- JM Vinuesa Hernando (ORCID: https://orcid.org/0000-0001-5378-859X)
Publication Details
- Journal
- Alternative Complementary & Integrative Medicine
- Published
- 2025-06-06
- DOI
- https://doi.org/10.24966/acim-7562/100596
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00